Atrinsic (PTIX) Competitors $3.43 -0.05 (-1.44%) As of 12:58 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesSEC FilingsShort InterestTrendsBuy This Stock PTIX vs. SVT, TRAW, OBSV, GOVX, CLDI, PMCB, LIXT, ORGS, GNPX, and GTBPShould you be buying Atrinsic stock or one of its competitors? The main competitors of Atrinsic include Servotronics (SVT), Traws Pharma (TRAW), ObsEva (OBSV), GeoVax Labs (GOVX), Calidi Biotherapeutics (CLDI), Nuvilex (PMCB), Lixte Biotechnology (LIXT), Orgenesis (ORGS), GENPREX (GNPX), and GT Biopharma (GTBP). Atrinsic vs. Its Competitors Servotronics Traws Pharma ObsEva GeoVax Labs Calidi Biotherapeutics Nuvilex Lixte Biotechnology Orgenesis GENPREX GT Biopharma Servotronics (NYSEAMERICAN:SVT) and Atrinsic (NASDAQ:PTIX) are related small-cap companies, but which is the better investment? We will compare the two businesses based on the strength of their earnings, institutional ownership, profitability, analyst recommendations, risk, valuation, dividends and media sentiment. Which has higher valuation & earnings, SVT or PTIX? Servotronics has higher revenue and earnings than Atrinsic. Atrinsic is trading at a lower price-to-earnings ratio than Servotronics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioServotronics$44.92M2.68-$1.62M$0.05938.99AtrinsicN/AN/A-$5.53M-$13.11-0.26 Is SVT or PTIX more profitable? Atrinsic has a net margin of 0.00% compared to Servotronics' net margin of -2.32%. Servotronics' return on equity of -1.23% beat Atrinsic's return on equity.Company Net Margins Return on Equity Return on Assets Servotronics-2.32% -1.23% -0.82% Atrinsic N/A -860.52%-354.19% Which has more risk and volatility, SVT or PTIX? Servotronics has a beta of 1.49, suggesting that its stock price is 49% more volatile than the S&P 500. Comparatively, Atrinsic has a beta of 0.34, suggesting that its stock price is 66% less volatile than the S&P 500. Do institutionals and insiders believe in SVT or PTIX? 24.8% of Servotronics shares are owned by institutional investors. Comparatively, 8.0% of Atrinsic shares are owned by institutional investors. 33.9% of Servotronics shares are owned by company insiders. Comparatively, 35.0% of Atrinsic shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term. Does the media prefer SVT or PTIX? In the previous week, Atrinsic had 1 more articles in the media than Servotronics. MarketBeat recorded 1 mentions for Atrinsic and 0 mentions for Servotronics. Atrinsic's average media sentiment score of 1.87 beat Servotronics' score of 0.00 indicating that Atrinsic is being referred to more favorably in the news media. Company Overall Sentiment Servotronics Neutral Atrinsic Very Positive SummaryServotronics beats Atrinsic on 7 of the 12 factors compared between the two stocks. Get Atrinsic News Delivered to You Automatically Sign up to receive the latest news and ratings for PTIX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding PTIX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart PTIX vs. The Competition Export to ExcelMetricAtrinsicMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$2.02M$2.92B$5.56B$9.26BDividend YieldN/A2.43%4.23%4.03%P/E Ratio-0.2620.2728.6119.56Price / SalesN/A298.79437.49183.65Price / CashN/A43.1536.0257.93Price / Book1.757.668.185.58Net Income-$5.53M-$55.11M$3.23B$257.82M7 Day Performance-10.44%0.03%-0.25%-0.39%1 Month Performance1.18%7.47%5.40%7.80%1 Year Performance-66.02%-3.28%26.35%12.95% Atrinsic Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)PTIXAtrinsic0.5282 of 5 stars$3.43-1.4%N/A-66.9%$2.02MN/A-0.262Positive NewsSVTServotronicsN/A$46.94flatN/AN/A$120.17M$44.92M-109.16270TRAWTraws Pharma0.6125 of 5 stars$1.45flatN/AN/A$8.07M$230K-0.0417OBSVObsEvaN/AN/AN/AN/A$7.94MN/A-0.1150Gap DownGOVXGeoVax Labs2.2181 of 5 stars$0.50+4.6%$11.10+2,110.3%-75.4%$7.65M$3.95M-0.1410Analyst UpgradeCLDICalidi Biotherapeutics0.5623 of 5 stars$0.24-2.3%N/A-67.1%$7.64MN/A0.0038Gap UpPMCBNuvilex2.9923 of 5 stars$1.10-0.9%N/A-46.6%$7.62MN/A1.494Gap UpLIXTLixte Biotechnology0.2417 of 5 stars$2.24-20.8%N/A+53.9%$7.60MN/A-1.544Gap DownHigh Trading VolumeORGSOrgenesisN/A$1.51+13.5%N/AN/A$7.25M$662K0.00150GNPXGENPREX1.3289 of 5 stars$0.26-1.2%N/A-85.2%$7.24MN/A0.0020GTBPGT Biopharma2.2257 of 5 stars$2.17-22.5%$11.00+406.9%-29.3%$7.23MN/A-0.388Gap Up Related Companies and Tools Related Companies Servotronics Alternatives Traws Pharma Alternatives ObsEva Alternatives GeoVax Labs Alternatives Calidi Biotherapeutics Alternatives Nuvilex Alternatives Lixte Biotechnology Alternatives Orgenesis Alternatives GENPREX Alternatives GT Biopharma Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:PTIX) was last updated on 7/16/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredRevolutionary AI Tech Targets Early Diabetic Blindness Detection FDA Trial UnderwayTiny Stock, Massive Potential— this company’s AI platform is a game changer for healthcare!Interactive Offers | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredCentral Banks Are Hoarding Gold – Should You?The AI boom isn’t just transforming technology—it’s redefining global power, increasing government debt, and u...Lear Capital | SponsoredSpecial gold investment soars 2,300% ... 5,090% ... 9,850%In my 54 years as an investor, I’ve seen my share of gold bull markets. But nothing comes close to the rall...Weiss Ratings | SponsoredAll New Social Security Numbers coming July 23?To All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | Sponsored"Death Spiral" Threatening Your SavingsThe "Death Spiral" Threatening Your Savings But this time, it's not just Dalio ringing the alarm bells…GoldCo Precious Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Atrinsic Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Atrinsic With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free PTIX Stock Alerts